Coherus Eyeing US Pegfilgrastim Bulk With On-Body Injector Approval

Amgen’s Onpro Version Commands the >40% Of The US Market

 
• By Dean Rudge
  
Complete Word Jigsaw Pieces
• Source: Cagkan Sayin / Alamy Stock Photo

More from Products

More from Generics Bulletin